BioSpace News Archive

MAZ World and ZEAL Cosmetics have confirmed that Ostrich Antibodies are effective in neutralising all four serotypes of Dengue Viruses; providing a new avenue for dengue prevention and/or treatment

Early data from ongoing Phase 1/2 clinical trial with NOX-A12 shows promising immune responses in patients

ADOCIA announces that Eli Lilly and Company (“Lilly”) filed a complaint against Adocia in the United States District Court of the Southern District of Indiana on October 9th, 2018.

OBN (UK) Ltd is delighted to announce the winners of the 2018 OBN Awards.

Weeks after Waltham, Mass.-based Morphic Therapeutic secured $80 million in Series B financing that was supported in part by AbbVie Ventures, the company struck a deal with the pharma giant to collaborate on the development of therapies for fibrosis-related indications.

TIME Magazine came out with a list of the 50 most influential people in healthcare, dubbed The Health Care 50. A look through the list shows just how many ties and connections—as well as influence—this group has on the biopharma industry.

VisionGate, Inc. is pleased to announce the appointment of R. John Glasspool as its Chief Operating and Strategy Officer.

Eisai Co., Ltd. has announced that the National Medical Products Administration of China has accepted for review a New Drug Application for Eisai’s antiepileptic drug (AED) perampanel as an adjunctive treatment for partial onset seizures in epilepsy patients 12 years of age and older. This NDA is the first to be submitted for perampanel in China.

Shvabe Holding, part of Russian State Corporation Rostec, is ready to assist its Indian partners in the creation, equipping and reequipping of hospitals and medical centers. The Holding is prepared to supply the country with a wide range of high-tech medical products, in fields ranging from diagnostics to VR rehabilitation.

Company awarded for excellence in innovation for Parteck® MXP Excipient and modified amino acids